Acute generalized exanthematous pustulosis

Background

  • T-cell mediated rash with systemic features
  • >90% of cases attributable to a medication (usually an antibiotic)
  • Mortality rate of ~5%

Clinical Features

Acute generalized exanthematous pustulosis
  • Onset 1-5 days after starting causative medication
  • Rash:
    • Large areas of edematous erythema with numerous small, non-follicular pustules
    • Predominantly affects main body folds and upper trunk, but can involve face
    • NO mucous membrane involvement (in contrast to SJS/TEN)
  • Systemic findings:

Differential Diagnosis

Erythematous rash

Evaluation

Workup

  • Clinical diagnosis
  • CBC
  • BMP
  • LFTs

Diagnosis

Table of Severe Drug Rashes

Charateristic DRESS SJS/TEN AGEP Erythroderma
Image
Onset of eruption2-6 weeks1-3 weeks48 hours1-3 weeks
Duration of eruption (weeks)Several1-3<1Several
Fever++++++++++++
Mucocutaneous featuresFacial edema, morbilliform eruption, pustules, exfoliative dermattiis, tense bullae, possible target lesionsBullae, atypical target lesions, mucocutaneous erosionsFacial edema, pustules, tense bullae, possible target lesions, possibl emucosal involvementErythematous plaques and edema affecting >90% of total skin surface with or without diffuse exfoliation
Lymph node enlargement+++-++
NeutrophilsElevatedDecreasedVery elevatedElevated
EosinophilsVery elevatedNo changeElevatedElevated
Atypical lymphocytes+--+
Hepatitis+++++++-
Other organ involvementInterstitial nephritis, pneumonitis, myocarditis, and thydoiditisTubular nephritis and tracheobronical necrosisPossiblePossible
Histological pattern of skinPerivascular lymphocytcic infiltrateEpidermal necrosisSubcorneal pustulesNonspecific, unless reflecting Sezary syndrome or other lymphoma
Lymph node histologyLymphoid hyperplasia--No, unless reflecting Sezary syndrome or other malignancy
Mortality (%)105-3555-15

Management

  • Stop inciting agent
  • IVF- treat similar to fluid resuscitation in burns
  • Wound care, infection control

Disposition

  • Admit

See Also

References

    This article is issued from Wikem. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.